Abeona Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | -1,667 | -724 |
EBITDA | -7,435 | -28,445 | 10,145 | -29,901 |
EBIT | -8,211 | -29,167 | 8,478 | -30,625 |
Net Income | -9,293 | -30,269 | 7,406 | -31,578 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,165 | -12,638 | -13,395 | -15,263 |
Cash | 23,357 | 15,726 | 34,426 | 17,558 |
Basic Shares | 43,471 | 48,081 | 51,226 | 27,315 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $3,500 | $1,414 | $3,000 |
Gross Profit | 0 | 1,895 | 964 | -1,464 |
EBITDA | -64,211 | -50,572 | -34,383 | -76,802 |
EBIT | -53,770 | -38,960 | -81,266 | |
Net Income | -63,734 | -54,188 | -31,809 | -88,606 |
Net Change In Cash | 0 | 3,500 | 1,414 | 3,000 |
Free Cash Flow | -58,461 | -37,340 | -43,613 | -69,816 |
Cash | 23,357 | 14,473 | 14,217 | 32,938 |
Basic Shares | 410,482 | 21,380 | 7,861 | 3,937 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.31 |
2024-09-30 | -$0.31 |
2024-06-30 | $0.19 |
2024-03-31 | -$1.16 |
